Ethical considerations in paediatric neurology: neuromuscular disease and epilepsy

Area of Science:

• Medical Ethics
• Neurology
• Bioethics

Background:

• Rapid technological advancements in diagnostics and treatments, such as artificial ventilation, challenge ethical decision-making in patient care.
• The question of who should make critical medical choices—physicians or patients and families—is a central ethical dilemma.
• Ethical considerations are particularly complex in neurological disorders like Duchenne muscular dystrophy and epilepsy.

Purpose of the Study:

• To review the ethical aspects of decision-making in neuromuscular disorders and epilepsy.
• To discuss the role of genetic testing, early interventions, and advanced treatments in managing these conditions.
• To explore the impact of financial and human costs on the accessibility of medical treatments and testing.

Main Methods:

• Review of ethical considerations in Duchenne muscular dystrophy (DMD), including genetic testing, wheelchair use, and invasive ventilation.
• Discussion of neurosurgery appropriateness for severely impaired children with epilepsy, family-centered decision-making.
• Analysis of financial and human costs as constraints on medical therapies and diagnostic testing.

Main Results:

• Ethical decision-making in neurological disorders lags behind technological progress.
• Individualized treatment choices, such as genetic testing for DMD or neurosurgery for epilepsy, require careful ethical deliberation.
• Financial and human costs significantly impact treatment and testing availability, presenting a practical ethical reality.

Conclusions:

• Ethical frameworks must evolve to guide complex decisions in neurological care.
• Patient and family involvement is crucial in navigating advanced treatment options.
• The reality of healthcare costs necessitates ethical consideration in resource allocation for medical interventions.